日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLL

体能和剂量强度对慢性淋巴细胞白血病患者接受维奈托克-奥妥珠单抗治疗的临床疗效的影响

Al-Sawaf, Othman; Fürstenau, Moritz; Giza, Adam; Robrecht, Sandra; von Tresckow, Julia; Fink, Anna-Maria; Simon, Florian; Tausch, Eugen; Schneider, Christof; Sivcheva, Liliya; Schwarer, Anthony; Loscertales, Javier; Weinkove, Robert; Strumberg, Dirk; Kilfoyle, Allanah; Juliusson, Gunnar; da Cunha-Bang, Caspar; Illmer, Thomas; Gregor, Michael; Thornton, Patrick; Janssens, Ann; Tadmor, Tamar; Lindström, Vesa; Staber, Philipp; Levin, Mark-David; Wendtner, Clemens-Martin; Kreuzer, Karl-Anton; Ritgen, Matthias; Stilgenbauer, Stephan; Kater, Arnon P; Niemann, Carsten; Fischer, Kirsten; Eichhorst, Barbara; Hallek, Michael

Pharmacogenetic Biomarkers of Ibrutinib Response and Toxicity in Chronic Lymphocytic Leukemia: Insights from an Observational Study

慢性淋巴细胞白血病中伊布替尼疗效和毒性的药物遗传学生物标志物:一项观察性研究的启示

Pérez-Gómez, Noelia; Sanz-Solas, Antonio; Cuevas, Beatriz; Cuevas, María Victoria; Alonso-Madrigal, Cristina; Loscertales, Javier; Álvarez-Nuño, Rodolfo; García, Covadonga; Zubiaur, Pablo; Villapalos-García, Gonzalo; Parra-Garcés, Raúl Miguel; Mejía-Abril, Gina; Alcaraz, Raquel; Vinuesa, Raquel; Díaz-Gálvez, Francisco Javier; González-Oter, María; García-Sancha, Natalia; Azibeiro-Melchor, Raúl; González-López, Tomás José; Abad-Santos, Francisco; Labrador, Jorge; Saiz-Rodríguez, Miriam

T-cell prolymphocytic leukemia, a case report and review of the literature

T细胞前淋巴细胞白血病:病例报告及文献综述

GONZáLEZ-RODRíGUEZ, Luis Manuel; JUáREZ-Salcedo, Luis Miguel; Loscertales, Javier; Arranz, Eva; Cannata-Ortiz, Jimena; Ortiz, Javier; LA Osa, Maria JOSé LóPEZ DE; Alegre, ADRIáN; Dalia, Samir

Observational retrospective study of the treatment of Waldenström's macroglobulinemia with ibrutinib in routine clinical practice in Spain

西班牙常规临床实践中采用伊布替尼治疗华氏巨球蛋白血症的回顾性观察研究

Fernández de Larrea, Carlos; Loscertales, Javier; Cabañas, Valentín; Freiria, Carmen; Blanchard, María Jesús; Askari, Elham; Lorenzo Pérez, Marcos; Abril, Laura; López Pardo, Jordi; Pinzón, Sergio; Díaz Gálvez, Javier; Amer, Neus; Ramírez Páyer, Ángel; García Sánchez, Ricarda; Alcalá, María Magdalena; Capote, Francisco Javier; Moreno, David; Bolumburu, Celia; Rubio-Azpeitia, Eva; García Sanz, Ramón

Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized phase 3 CLL14 study

维奈托克联合奥妥珠单抗治疗既往未接受治疗的慢性淋巴细胞白血病:随机3期CLL14研究的6年结果

Al-Sawaf, Othman; Robrecht, Sandra; Zhang, Can; Olivieri, Stefano; Chang, Yi Meng; Fink, Anna Maria; Tausch, Eugen; Schneider, Christof; Ritgen, Matthias; Kreuzer, Karl-Anton; Sivchev, Liliya; Niemann, Carsten Utoft; Schwarer, Anthony; Loscertales, Javier; Weinkove, Robert; Strumberg, Dirk; Kilfoyle, Allanah; Manzoor, Beenish S; Jawaid, Dureshahwar; Emechebe, Nnadozie; Devine, Jacob; Boyer, Michelle; Runkel, Eva D; Eichhorst, Barbara; Stilgenbauer, Stephan; Jiang, Yanwen; Hallek, Michael; Fischer, Kirsten

Real-World Evidence on Adverse Events and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukaemia in Spain Using Natural Language Processing: The SRealCLL Study

利用自然语言处理技术获取西班牙慢性淋巴细胞白血病患者不良事件和医疗资源利用的真实世界证据:SRealCLL 研究

Abrisqueta-Costa, Pau; García-Marco, José Antonio; Gutiérrez, Antonio; Hernández-Rivas, José Ángel; Andreu-Lapiedra, Rafael; Arguello-Tomas, Miguel; Leiva-Farré, Carolina; López-Roda, María Dolores; Callejo-Mellén, Ángel; Álvarez-García, Esther; Loscertales, Javier

Real-World Evidence on the Clinical Characteristics and Management of Patients with Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL Study

利用自然语言处理技术获取西班牙慢性淋巴细胞白血病患者临床特征和管理方面的真实世界证据:SRealCLL 研究

Loscertales, Javier; Abrisqueta-Costa, Pau; Gutierrez, Antonio; Hernández-Rivas, José Ángel; Andreu-Lapiedra, Rafael; Mora, Alba; Leiva-Farré, Carolina; López-Roda, María Dolores; Callejo-Mellén, Ángel; Álvarez-García, Esther; García-Marco, José Antonio

CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia.

CCR7 作为 T 细胞前淋巴细胞白血病的新型治疗靶点

Cuesta-Mateos Carlos, Fuentes Patricia, Schrader Alexandra, Juárez-Sánchez Raquel, Loscertales Javier, Mateu-Albero Tamara, Vega-Piris Lorena, Espartero-Santos Marina, Marcos-Jimenez Ana, Sánchez-López Blanca Andrea, Pérez-García Yaiza, Jungherz Dennis, Oberbeck Sebastian, Wahnschaffe Linus, Kreutzman Anna, Andersson Emma I, Mustjoki Satu, Faber Edgar, Urzainqui Ana, Fresno Manuel, Stamatakis Kostantino, Alfranca Arantzazu, Terrón Fernando, Herling Marco, Toribio María Luisa, Muñoz-Calleja Cecilia

Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma

伊布替尼联合苯达莫司汀和利妥昔单抗治疗复发/难治性慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者的3期HELIOS研究的最终5年结果

Fraser, Graeme A M; Chanan-Khan, Asher; Demirkan, Fatih; Santucci Silva, Rodrigo; Grosicki, Sebastian; Janssens, Ann; Mayer, Jiri; Bartlett, Nancy L; Dilhuydy, Marie-Sarah; Loscertales, Javier; Avigdor, Abraham; Rule, Simon; Samoilova, Olga; Pavlovsky, Miguel A; Goy, Andre; Mato, Anthony; Hallek, Michael; Salman, Mariya; Tamegnon, Monelle; Sun, Steven; Connor, Anne; Nottage, Kerri; Schuier, Natasha; Balasubramanian, Sriram; Howes, Angela; Cramer, Paula

Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia

一项随机 II 期研究,比较奥妥珠单抗联合苯达莫司汀与单用苯达莫司汀治疗复发性慢性淋巴细胞白血病患者的疗效。

Robak, Tadeusz; Hellmann, Andrzej; Kloczko, Janusz; Loscertales, Javier; Lech-Maranda, Ewa; Pagel, John M; Mato, Anthony; Byrd, John C; Awan, Farrukh T; Hebart, Holger; Garcia-Marco, Jose A; Hill, Brian T; Hallek, Michael; Eisenfeld, Amy J; Stromatt, Scott C; Jaeger, Ulrich